Core Insights - The US Department of Commerce has initiated an investigation into the national security implications of importing medical devices and healthcare equipment, leading to a decline in medtech stock prices on September 25 [1][3] - The investigation is part of a broader review under Trump's Section 232, which has previously resulted in tariffs on various goods [1][2] Industry Impact - Stock prices for major companies such as GE HealthCare and Becton Dickinson fell by over 4% on September 25, closing at $71.50 and $180.59 respectively, with other companies like Intuitive Surgical and Insulet also experiencing declines [3] - The Department of Commerce is seeking feedback within a 21-day window regarding the national security effects of importing medical devices, consumables, and personal protective equipment [3][4] Areas of Interest - The DOC is particularly focused on potential export restrictions by foreign nations, the feasibility of reducing import reliance, and the impact of foreign government subsidies and predatory trade practices on competitiveness [5] - The Advanced Medical Technology Association (AdvaMed) expressed a cautiously optimistic view regarding the investigation, emphasizing the strength of US medtech manufacturing and the potential benefits of lower tariffs [5][6]